BMS-354825 (BMS) inhibits the kinase activity of mutant KIT proteins associated with seminomas (S) and has synergistic effects with cisplatin (CDDP) No significant financial relationships to disclose.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback